top of page
Sleep Apnea and Obesity: Risks, Policy, and Tirzepatide (Zepbound®)
As part of the Alliance of Sleep Apnea Partners' Breathing Room series, UC San Diego sleep medicine researcher Dr. Chris Schmickl and Dr. Tracy Zvenyach, a registered nurse and Ph.D. who is also a policy expert, share valuable insights about the sleep apnea - obesity connection, as well as treatment approaches, including the medication tirzepatide (Zepbound).
Three Ways Sleep Apnea Patients Can Lower Zepbound® Costs
Liz Paul worked with her doctor and was able to cut her out-of-pocket cost for Zepbound to about $60 for a year. Photo: Courtesy of Liz...
bottom of page